Viventop SRL
0.6 FTEViventop reported total assets of 460,629 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jul 2026), with 0.6 full-time equivalent.
The score of Viventop shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -14 % Headcount (avg FTE) -88 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Viventop's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jul 2026
- Year ended 31 Dec 2024filed on 22 Jul 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
- Year ended 31 Dec 2022filed on 19 Jun 2023
- Year ended 31 Dec 2021filed on 27 Jun 2022
Viventop's financial analysis
- Solvency10.3%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Viventop
Viventop's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0825.370.327
- VAT number
- BE0825370327
- Peppol
- Registered · 0208:0825370327 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Apr 2010
- Registered office
- 5060 Sambreville
- Size
- Micro · 0.6 FTE
- Latest accounts
- 2025 · filed on 30 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Viventop (SRL) has been based in Sambreville since 2010, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 1,506 € and equity of 47,465 €; its revenue is not published. With 0.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 10.3%, below the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Viventop
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Vandenabeele Retail sale of pharmaceutical products Antwerp · balance sheet 509,264 €
- Pharma de Cock Retail sale of pharmaceutical products Ingelmunster · balance sheet 587,807 €
- Pharmacie Veeweyde Centre Retail sale of pharmaceutical products Anderlecht · balance sheet €1.55m
- DUGO Retail sale of pharmaceutical products Zuienkerke · balance sheet 419,728 €
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- Antoine Derbaud Retail sale of pharmaceutical products Ham-sur-Heure-Nalinnes · balance sheet 126,424 €
- AVA-Rose Retail sale of pharmaceutical products Jette · balance sheet 381,859 €
- A.Catrin Pharma Retail sale of pharmaceutical products Ham-sur-Heure-Nalinnes · balance sheet 94,339 €
Frequently asked questions about Viventop
What is the revenue of Viventop?
Viventop files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Viventop?
In Belgium, the VAT number is the company number prefixed with BE: BE0825370327 for Viventop, if the company is VAT-registered. Its company number (CBE) is 0825.370.327.
Where is the registered office of Viventop?
According to the CBE register, the registered office of Viventop is in 5060 Sambreville.
What is the equity of Viventop?
At the close of the 2025 financial year, the equity of Viventop amounts to 47,465 €, a solvency of 10.3% of total assets.
How many people work at Viventop?
0.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Viventop?
The register lists 2 active mandates at Viventop. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Viventop
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →